Aya Kitae
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aya Kitae has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Masahide Hamaguchi
Department of Endocrinology and Metabolism Kyoto Prefectural University of Medicine, Graduate School of Medical Science Kyoto Japan
4 shared publications - Michiaki Fukui
Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan
3 shared publications - Emi Ushigome
Department of Fundamental Science Kyoto Institute of Technology Kyoto Japan
2 shared publications Masahiro Yamazaki
Department of Endocrinology and Metabolism Kyoto Prefectural University of Medicine, Graduate School of Medical Science Kyoto Japan
2 shared publications- Takafumi Osaka
Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan
2 shared publications - Yoshitaka Hashimoto
Department of Diabetes and Endocrinology, Matsushita Memorial Hospital, Moriguchi 570-8540, Japan
2 shared publications
Latest Publications
- 3 June 2021
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 23 (9) , 2155-2160
Development of application to automatically calculate mean amplitude of glycaemic excursions using intermittently scanned continuous glucose monitoring data
Aim: We aimed to develop an application to calculate mean amplitude of glycaemic excursions (MAGE) automatically and to evaluate its accuracy. Materials and Methods: We named the application intermittently scanned continuous glucose monitoring (isCGM) calculator KAMOGAWA (Kyoto Auto MAGE Of Glucose cAlcutator With isCGM Application). The isCGM data from 20 patients, 10 with and 10 without diabetes, were used to compare manually calculated MAGE values with those calculated using KAMOGAWA. The rate of agreement for the MAGE values was calculated. Results: Comparing the MAGE values calculated manually with those calculated using KAMOGAWA, the total mean rate of agreement was 81.6%. Nonmatching values were checked and it was found that the inconsistencies were all attributable to errors in manual calculations. After correcting errors in the manual calculation, the MAGE values matched to one decimal place for all data in the manual and KAMOGAWA calculations. Conclusions: KAMOGAWA can help diabetologists use MAGE in clinical practice, which could contribute to improving glycaemic control in patients who use isCGM.
- 3 June 2021
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 23 (9) , 2155-2160
Development of application to automatically calculate mean amplitude of glycaemic excursions using intermittently scanned continuous glucose monitoring data
Aim: We aimed to develop an application to calculate mean amplitude of glycaemic excursions (MAGE) automatically and to evaluate its accuracy. Materials and Methods: We named the application intermittently scanned continuous glucose monitoring (isCGM) calculator KAMOGAWA (Kyoto Auto MAGE Of Glucose cAlcutator With isCGM Application). The isCGM data from 20 patients, 10 with and 10 without diabetes, were used to compare manually calculated MAGE values with those calculated using KAMOGAWA. The rate of agreement for the MAGE values was calculated. Results: Comparing the MAGE values calculated manually with those calculated using KAMOGAWA, the total mean rate of agreement was 81.6%. Nonmatching values were checked and it was found that the inconsistencies were all attributable to errors in manual calculations. After correcting errors in the manual calculation, the MAGE values matched to one decimal place for all data in the manual and KAMOGAWA calculations. Conclusions: KAMOGAWA can help diabetologists use MAGE in clinical practice, which could contribute to improving glycaemic control in patients who use isCGM.
- Open Access
- 1 May 2021
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 12 (5) , 894-896
Transition of blood glucose level in a patient with pregnancy-associated fulminant type 1 diabetes mellitus
We report on the transition in blood glucose levels before and after the onset of fulminant type 1 diabetes mellitus in a perinatal woman. In week 38 of pregnancy, before which the patient had normal glucose tolerance, idiopathic acute pancreatitis was diagnosed. Five days thereafter, she became hypoglycemic, so we closely monitored her blood glucose levels. A total of 13 days later, she was hyperglycemic with a blood glucose level >16.0 mmol/L and glycated hemoglobin of 6.4%. Her fasting serum C-peptide reactivity level was 3.6 ng/mL on the 5th day, and 0.2 ng/mL on the 18th day. Multiple insulin injection therapy was administered since the 18th day; after that, ketoacidosis did not occur. The patient was diagnosed with fulminant type 1 diabetes mellitus based on hyperglycemia without high glycated hemoglobin levels and sudden onset insulin-dependent diabetes. Monitoring glucose levels in the case of idiopathic acute pancreatitis during pregnancy and prompt initiation of insulin therapy are important.
- 1 May 2021
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 12 (5) , 894-896
Open AccessTransition of blood glucose level in a patient with pregnancy-associated fulminant type 1 diabetes mellitus
We report on the transition in blood glucose levels before and after the onset of fulminant type 1 diabetes mellitus in a perinatal woman. In week 38 of pregnancy, before which the patient had normal glucose tolerance, idiopathic acute pancreatitis was diagnosed. Five days thereafter, she became hypoglycemic, so we closely monitored her blood glucose levels. A total of 13 days later, she was hyperglycemic with a blood glucose level >16.0 mmol/L and glycated hemoglobin of 6.4%. Her fasting serum C-peptide reactivity level was 3.6 ng/mL on the 5th day, and 0.2 ng/mL on the 18th day. Multiple insulin injection therapy was administered since the 18th day; after that, ketoacidosis did not occur. The patient was diagnosed with fulminant type 1 diabetes mellitus based on hyperglycemia without high glycated hemoglobin levels and sudden onset insulin-dependent diabetes. Monitoring glucose levels in the case of idiopathic acute pancreatitis during pregnancy and prompt initiation of insulin therapy are important.
- Open Access
- 30 September 2020
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 12 (5) , 837-844
Asymptomatic postprandial hypotension in patients with diabetes: The KAMOGAWA‐HBP study
Aims/Introduction: Postprandial hypotension (PPH) refers to a decrease in systolic blood pressure by ≥20 or to P < 0.001), after adjusting for covariates. Furthermore, age (OR 1.08, 95% CI 1.01–1.16, P = 0.027), hemoglobin A1c level (OR 2.39, 95% CI 1.01–5.64, P = 0.030) and coefficients of variation of R‐R intervals (OR 0.79, 95% CI 0.65–0.97, P = 0.032) were significantly associated with asymptomatic PPH.Conclusions: Half of the present study outpatients with diabetes had PPH. High systolic blood pressure before a meal was significantly associated with the risk of PPH. Older adults and patients with higher levels of hemoglobin A1c or an autonomic dysfunction might have difficulties recognizing symptoms of PPH.
- 30 September 2020
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 12 (5) , 837-844
Open AccessAsymptomatic postprandial hypotension in patients with diabetes: The KAMOGAWA‐HBP study
Aims/Introduction: Postprandial hypotension (PPH) refers to a decrease in systolic blood pressure by ≥20 or to P < 0.001), after adjusting for covariates. Furthermore, age (OR 1.08, 95% CI 1.01–1.16, P = 0.027), hemoglobin A1c level (OR 2.39, 95% CI 1.01–5.64, P = 0.030) and coefficients of variation of R‐R intervals (OR 0.79, 95% CI 0.65–0.97, P = 0.032) were significantly associated with asymptomatic PPH.Conclusions: Half of the present study outpatients with diabetes had PPH. High systolic blood pressure before a meal was significantly associated with the risk of PPH. Older adults and patients with higher levels of hemoglobin A1c or an autonomic dysfunction might have difficulties recognizing symptoms of PPH.
- Open Access
- 7 October 2019
- Published by Wiley in Canadian Journal of Gastroenterology and Hepatology
- Vol. 2019, 1-7
The Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Background. The triglyceride and glucose index (TyG), defined as the product of triglycerides (TG) and fasting plasma glucose (FPG), is reported as a surrogate index for insulin resistance. Although a cross-sectional study revealed the association between the TyG-index and the prevalence of nonalcoholic fatty liver disease (NAFLD), few studies have investigated the association between the TyG-index and incident NAFLD. Here we investigated whether the TyG-index can be used to predict incident NAFLD. Methods. This historical cohort study included 16,093 apparently healthy Japanese individuals. The TyG-index was calculated by the established formula: TyG = Ln [TG (mg/dl) × FPG (mg/dl)/2]. Fatty liver was diagnosed based on the subjects’ abdominal ultrasonography results. We divided the subjects into tertiles according to the levels of TyG-index. Hazard ratios (HRs) of the TyG-index for incident NAFLD were calculated by a Cox proportional hazards regression model. Results. During the observation period, 27.4% of the men and 11.0% of the women developed NAFLD. The highest TyG-index tertile (men, 8.48 ≤ TyG and women, 7.97 ≤ TyG) (adjusted HR 1.67, 95% CI 1.44–1.94, in the men and 2.06, 1.59–2.70, in the women) and the middle TyG-index tertile (men, 8.00 < TyG ≤ 8.48 and women, 7.53 <TyG ≤7.97) (1.33, 1.15–1.54, in the men and 1.52, 1.16–2.01, in the women) presented a significantly higher risk of incident NAFLD compared to the lowest TyG-index tertile (men, TyG < 8.00 and women, TyG < 7.53). Conclusions. Our findings demonstrate that the TyG-index is significantly associated with incident NAFLD.- 7 October 2019
- Published by Wiley in Canadian Journal of Gastroenterology and Hepatology
- Vol. 2019, 1-7
Open AccessThe Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Background. The triglyceride and glucose index (TyG), defined as the product of triglycerides (TG) and fasting plasma glucose (FPG), is reported as a surrogate index for insulin resistance. Although a cross-sectional study revealed the association between the TyG-index and the prevalence of nonalcoholic fatty liver disease (NAFLD), few studies have investigated the association between the TyG-index and incident NAFLD. Here we investigated whether the TyG-index can be used to predict incident NAFLD. Methods. This historical cohort study included 16,093 apparently healthy Japanese individuals. The TyG-index was calculated by the established formula: TyG = Ln [TG (mg/dl) × FPG (mg/dl)/2]. Fatty liver was diagnosed based on the subjects’ abdominal ultrasonography results. We divided the subjects into tertiles according to the levels of TyG-index. Hazard ratios (HRs) of the TyG-index for incident NAFLD were calculated by a Cox proportional hazards regression model. Results. During the observation period, 27.4% of the men and 11.0% of the women developed NAFLD. The highest TyG-index tertile (men, 8.48 ≤ TyG and women, 7.97 ≤ TyG) (adjusted HR 1.67, 95% CI 1.44–1.94, in the men and 2.06, 1.59–2.70, in the women) and the middle TyG-index tertile (men, 8.00 < TyG ≤ 8.48 and women, 7.53 <TyG ≤7.97) (1.33, 1.15–1.54, in the men and 1.52, 1.16–2.01, in the women) presented a significantly higher risk of incident NAFLD compared to the lowest TyG-index tertile (men, TyG < 8.00 and women, TyG < 7.53). Conclusions. Our findings demonstrate that the TyG-index is significantly associated with incident NAFLD.